Description
MGCD-265 Analog is an inhibitor of MET that may exhibit anticancer potential.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MGCD-265 Analog is an inhibitor of MET that may exhibit anticancer potential.
| Cas No. | 875337-44-3 |
|---|---|
| Purity | ≥98% |
| Formula | C26H20FN5O2S2 |
| Formula Wt. | 517.60 |
| Chemical Name | N-[[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-phenylacetamide |
| IUPAC Name | N-[[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-phenylacetamide |
| Synonym | MGCD-265; MGCD265; MGCD 265 Analog, MGCD265 Analog, MGCD-265 Analog, Glesatinib Analog |
| Solubility | DMSO 104 mg/mL (200.92 mM) Water Insoluble Ethanol Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Belalcazar A1, Azaña D, Perez CA, et al. Targeting the Met pathway in lung cancer. Expert Rev Anticancer Ther. 2012 Apr;12(4):519-28. PMID: 22500688.
Effective against gram-positive pathogens
Isothiocyanate found in cruciferous vegetables,...
Cationic lipid polypeptide, mixture of polymyxi...
Impurity of diclofenac
Synthesis impurity
Vitamin E component
Cephalomannine derivative found in Taxus; poten...
Quinoline; PDE 3B inhibitor.
Imidazoline and α2-adrenergic agonist, Nav1.7 ...
BCL-XL specific degrader
Recombinant protein containing Treponema pallid...
Endogenous tachykinin peptide, involved in infl...
H1 histamine and LT antagonist, PDE inhibitor.<...
NSAID; COX-2 inhibitor.
Vitamin E analog, antioxidant.
Mixture of Ginkgolides A, B and C, found in Gin...
Peptide, used to deliver conjugated drugs to ce...